•
NK
NKTR
Nektar Therapeutics
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
751.01M
Volume
31.89K
52W High
$66.92
52W Low
$6.48
Open
$36.92
Prev Close
$36.92
Day Range
36.76 - 37.99
About Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
Latest News
ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors
GlobeNewswire Inc.•Dec 2
Why Nektar Therapeutics Stock Popped 6% on Friday
The Motley Fool•Aug 8
Nektar's (NKTR) Q2 Earnings Lag Estimates, Revenues Top
Zacks Investment Research•Aug 9
Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
Zacks Investment Research•May 10
Nektar Therapeutics Sees Something In The Data And Puts Its Drug To The Test
Seeking Alpha•Apr 10
Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?
Zacks Investment Research•Apr 3
Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata
Zacks Investment Research•Mar 6
Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat
Zacks Investment Research•Mar 5